Cargando…
Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer
Metastasis is the leading cause of cancer-related deaths. A number of chemotherapeutic and early diagnosis strategies, including nanomedicine, have been developed to target metastatic tumor cells. However, simultaneous inhibition and imaging of metastasis is yet to be fully achieved. Methods: To ove...
Autores principales: | Lee, Hohyeon, Jang, Yongho, Park, Suhyun, Jang, Hyejin, Park, Eun-Joo, Kim, Hyun Jung, Kim, Hyuncheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096393/ https://www.ncbi.nlm.nih.gov/pubmed/30128051 http://dx.doi.org/10.7150/thno.25131 |
Ejemplares similares
-
Development of a Polymersome-Based Nanomedicine for Chemotherapeutic and Sonodynamic Combination Therapy
por: Kim, Mingyun, et al.
Publicado: (2023) -
Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
por: Tan, Junyi, et al.
Publicado: (2020) -
Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate
por: Jun, Yong Joo, et al.
Publicado: (2017) -
Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2019) -
Recent Advances in Photoacoustic Agents for Theranostic Applications
por: Han, Seongyi, et al.
Publicado: (2023)